{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:12:03Z","timestamp":1789816323135,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0088\/2021\/A,0023\/2023\/RIB1,0001\/2024\/AKP,0001\/2024\/RDP"],"award-info":[{"award-number":["0088\/2021\/A,0023\/2023\/RIB1,0001\/2024\/AKP,0001\/2024\/RDP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148170","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T06:54:38Z","timestamp":1759906478000},"page":"148170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P3","title":["The WT1 protein molecule drives the proliferation and metastasis of anaplastic thyroid carcinoma through the EMT process"],"prefix":"10.1016","volume":"330","author":[{"given":"Jiayu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-kuan","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Ieng","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10387","key":"10.1016\/j.ijbiomac.2025.148170_bb0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0015","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.surge.2023.10.002","article-title":"Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease","volume":"22","author":"Cleere","year":"2024","journal-title":"Surgeon"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148170_bb0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s11864-024-01219-y","article-title":"Promising therapeutic targets for recurrent\/metastatic anaplastic thyroid cancer","volume":"25","author":"Abdalla","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0025","article-title":"Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216496","article-title":"Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer","volume":"580","author":"Pan","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148170_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148170_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06694-7","article-title":"Targeting EMT using low-dose teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer","volume":"15","author":"Metge","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2006","journal-title":"Biostatistics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148170_bb0055","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the molecular signatures database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat. Methods"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148170_bb0060","doi-asserted-by":"crossref","first-page":"13206","DOI":"10.3390\/ijms241713206","article-title":"A risk model for prognosis and treatment response prediction in colon adenocarcinoma based on genes associated with the characteristics of the epithelial-mesenchymal transition","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137431","article-title":"Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of acute myocardial infarction","volume":"282","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.821855","article-title":"Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells","volume":"10","author":"Holm","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148170_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12022-013-9272-9","article-title":"The role of epithelial mesenchymal transition markers in thyroid carcinoma progression","volume":"24","author":"Montemayor-Garcia","year":"2013","journal-title":"Endocr. Pathol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148170_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40291-015-0175-y","article-title":"PI3K\/AKT pathway and its mediators in thyroid carcinomas","volume":"20","author":"Nozhat","year":"2016","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cancers14041061","article-title":"Anaplastic thyroid carcinoma: an update","volume":"14","author":"Jannin","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148170_bb0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148170_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cancers10020052","article-title":"The epithelial-to-mesenchymal transition in cancer","volume":"10","author":"Roche","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fonc.2020.00499","article-title":"EMT factors and metabolic pathways in cancer","volume":"10","author":"Georgakopoulos-Soares","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148170_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.148170_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euprot.2016.01.003","article-title":"Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics","volume":"10","author":"Vergara","year":"2016","journal-title":"EuPA Open Proteom."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.148170_bb0130","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-21-1538","article-title":"A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression","volume":"81","author":"Liang","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13046-018-0980-3","article-title":"IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways","volume":"37","author":"Duan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"50","key":"10.1016\/j.ijbiomac.2025.148170_bb0140","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","article-title":"Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2032 kinase\/AKT pathways","volume":"24","author":"Larue","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148170_bb0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.leu.2404624","article-title":"A tumor suppressor and oncogene: the WT1 story","volume":"21","author":"Yang","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12967-022-03260-7","article-title":"BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148170_bb0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ijc.28755","article-title":"Six1: a critical transcription factor in tumorigenesis","volume":"136","author":"Wu","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148170_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the Warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"issue":"38","key":"10.1016\/j.ijbiomac.2025.148170_bb0165","doi-asserted-by":"crossref","first-page":"33167","DOI":"10.1074\/jbc.M111.256644","article-title":"Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration","volume":"286","author":"Zarrabi","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-016-0262-7","article-title":"MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer","volume":"9","author":"Vos","year":"2016","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148170_bb0175","first-page":"950","article-title":"MMP14 regulates cell migration and invasion through epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"7","author":"Yan","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148170_bb0180","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1096\/fj.201801127R","article-title":"MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions","volume":"33","author":"Hillebrand","year":"2019","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148170_bb0185","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/cancers12082300","article-title":"Exosomes-mediated transfer of Itga2 promotes migration and invasion of prostate cancer cells by inducing epithelial-mesenchymal transition","volume":"12","author":"Gaballa","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148170_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/carcin\/bgad096","article-title":"ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation","volume":"45","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43141-022-00297-5","article-title":"Single nucleotide variants of receptor for advanced glycation end-products (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?\u2014a review","volume":"20","author":"Ahuja","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148170_bb0200","first-page":"4251","article-title":"Targeting c-kit inhibits gefitinib resistant NSCLC cell growth and invasion through attenuations of stemness, EMT and acquired resistance","volume":"10","author":"Zhou","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0205","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.1038\/s41598-021-97190-x","article-title":"The tumor suppressor miR-642a-5p targets Wilms tumor 1 gene and cell-cycle progression in prostate cancer","volume":"11","author":"Beveridge","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-12-3","article-title":"The Wilms\u2019 tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells","volume":"12","author":"Brett","year":"2013","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148170_bb0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12967-023-04538-0","article-title":"HOXD9\/miR-451a\/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K\/AKT signaling pathway in human anaplastic thyroid carcinoma","volume":"21","author":"Zhong","year":"2023","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148170_bb0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.trsl.2014.06.005","article-title":"Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma","volume":"164","author":"Milosevic","year":"2014","journal-title":"Transl. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025087276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025087276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:42:45Z","timestamp":1781743365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025087276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0141813025087276"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148170","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The WT1 protein molecule drives the proliferation and metastasis of anaplastic thyroid carcinoma through the EMT process","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148170"}}